We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
186 hedge funds and large institutions have $2.48B invested in Rocket Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 69 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
475% more call options, than puts
Call options by funds: $20.7M | Put options by funds: $3.6M
2.66% more ownership
Funds ownership: 99.4% → 102.06% (+2.7%)
10% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 63
4% less funds holding
Funds holding: 194 → 186 (-8)
7% less capital invested
Capital invested by funds: $2.69B → $2.48B (-$201M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
186
Holders Change
-8
Holders Change %
-4.12%
% of All Funds
2.68%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
19
Increased
69
Reduced
63
Closed
26
Calls
$20.7M
Puts
$3.6M
Net Calls
+$17.1M
Net Calls Change
-$3.37M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$47M |
| 2 |
State Street
Boston,
Massachusetts
|
+$27.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.2M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$22.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.2M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$19.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$17.7M |
| 3 |
Morgan Stanley
New York
|
-$15.2M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$8M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$5.18M |
